9-Me-BC is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of 9-Me-BC is not established. This means dosing once daily is typical to maintain stable levels. The half-life directly affects how long 9-Me-BC remains active and influences optimal injection timing.
What Is the Half-Life of 9-Me-BC?
The half-life of 9-Me-BC is not established. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer 9-Me-BC to maintain therapeutic blood levels.
What Does 9-Me-BC's Half-Life Mean for Dosing?
With a half-life of not established, 9-Me-BC requires dosing once daily to maintain stable levels. The standard dosage of 15-30 mg daily via oral or subcutaneous accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, 9-Me-BC reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For 9-Me-BC, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject 9-Me-BC?
Optimal timing depends on your research goals. A half-life of not established means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once daily) for more stable levels throughout the day.
How Does 9-Me-BC's Half-Life Compare to Similar Peptides?
9-Me-BC is a Monoamine oxidase inhibitor, neuroprotective agent. Its half-life of not established positions it with a longer duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your 9-Me-BC Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 9-Me-BC.
Open Calculator →Bottom Line: 9-Me-BC Half-Life and Dosing
9-Me-BC has a half-life of not established, supporting the standard protocol of 15-30 mg daily dosed once daily over 7-10 days (short cycles recommended due to MAO inhibition).
Read our 9-Me-BC dosage guide for complete protocol details.
Complete Guide
9-Me-BC : Benefits, Dosage, Side Effects & Research
Related Reading
- 9-Me-BC Dosage Guide
- 9-Me-BC Benefits
- 9-Me-BC Side Effects
- 9-Me-BC Stacking Guide
- 9-Me-BC Cycle Guide
- 9-Me-BC Research
Research-Grade Sourcing
If you're going to research 9-Me-BC, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 9-Me-BC?
9-Me-BC (9-Methyl-β-carboline) is a Monoamine oxidase inhibitor, neuroprotective agent. Synthetic indole alkaloid derivative targeting dopaminergic neuroprotection. It is researched for dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity.
What is the recommended 9-Me-BC dosage?
Common dosages: 15-30 mg daily administered once daily via oral or subcutaneous. Cycle length: 7-10 days (short cycles recommended due to MAO inhibition). Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of 9-Me-BC?
Dose-dependent toxicity at high concentrations in cell cultures. No human safety data available. As an MAO inhibitor, carries risk of tyramine interactions (avoid aged cheese, cured meats, fermented foods). Photosensitivity reported — avoid UV exposure during use.
Is 9-Me-BC safe?
9-Me-BC has shown a preliminary safety profile in research. Not FDA-approved. Research compound only. Unregulated. All research should follow appropriate safety protocols.